Barriers to the Treatment of Obesity

  1. George A. Bray, MD
  1. Pennington Biomedical Research Center
    Baton Rouge, LA 70808

    Excerpt

    There is clear and convincing evidence that modern appetite-suppressant drugs are effective and safe. However, there are several barriers to the proper use of these drugs and other treatments. These barriers include the public perception that obesity is a disease resulting from a lack of willpower, the professional expectation that appetite-suppressant drugs should cure obesity, hindrance by state licensing agencies, regulatory rigidity, limited research funding, and legislative grandstanding.

    Clinical and experimental data suggest that modern appetite-suppressant drugs have little risk (1, 2). Drug abuse with amphetamine, methamphetamine, and phenmetrazine is well recognized, and these drugs have no place in the

    This 100-word excerpt has been provided in the absence of an abstract.

    Article and Author Information

    • Requests for Reprints: George A. Bray, MD, Pennington Biomedical Research Center, 6400 Perkins Road, Baton Rouge, LA 70808.

    | Table of Contents
    Most Read Most Read
    Most Commented Most Commented On
    Annals in the News Annals in the News
    Clinical Trials Clinical Trials
    Comparative Effectiveness Comparative Effectiveness
    Hospital Medicine Hospital Medicine
    • Advertisement
    • Advertisement